Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Study characteristics for the included

From: Resistant starch ameliorated insulin resistant in patients of type 2 diabetes with obesity: a systematic review and meta-analysis

StudyStudy designSubjectsSample
Size (n)
Gender (Males/n)Age (years)
RS vs. Control
Baseline BMI (kg/m2)
RS vs. Control
RS dose (g/d)Duration (w)RS total dose (g)ControlWashout period (w)
Ble-Castillo 2010R,B, CT2DM284/2851.7 ± 5.634.89 ± 2.328.164228.5Soy milkDeclared none
Bodinham
2014
R, SB, CT2DM1712/1755 ± 2.430.6 ± 1.340123360RDS12
Karimi
2016
R, DB, PT2DM560/5649.5 ± 8.0
48.6 ± 7.9
31.5 ± 4.5
31 ± 4.9
108560MaltodextrinNon
existent
Kwak
2012
R, DB, PT2DM8547/8551.7 ± 2.03
49.4 ± 1.74
25 ± 0.49
24.5 ± 0.37
6.514182.3Cooked refined riceNon
existent
Zhang
2007
R, SB, CT2DM4017/4051.1 ± 7.9
52.2 ± 11.1
27.94 ± 2.5
26.87 ± 2.22
304840Wheatmeal1
Robertson 2012R, SB, CT2DM158/1548.9 ± 3.933.8 ± 1.94082240RDS8
Aliasgharzadeh 2015R,DB,PT2DM550/5549.2 ± 9.6
49.6 ± 8.4
31.8 ± 4.5
30.8 ± 5.2
108560MaltodextrinNon
existent
Gargari
2015
R,DB,PT2DM600/6049.5 ± 8.0
49.6 ± 8.4
31.5 ± 4.5
30.8 ± 5.2
108560MaltodextrinNon
existent
Dainty
2016
R, DB, CObesity2416/2455.3 ± 1.5930.2 ± 0.572581400Control wheat bagel4
Maki
2012
R, DB, CObesity3311/3349.5 ± 1.630.6 ± 0.5304840Control starch3
Johnston
2010
R, SB, PObesity2012/2045.2 ± 3.55
50.1 ± 4.05
31.3 ± 1.70
30.4 ± 1.15
40123360RDSNon
existent
Penn-Marshall 2010R, DB, CObesity178/1736.6 ± 1.5537.7 ± 2.0126504Control bread2
Maziarz 2017R, DB, PObesity183/1831.0 ± 3.0
31.2 ± 4.2
34.8 ± 1.5
30.6 ± 1.5
3061260Control muffinsNon
existent
Dodevska 2015RObesity4719/4758.4 ± 6.12
57.0 ± 6.13
33.06 ± 5.59
31.07 ± 5.03
8.3523029Fibre
(contain RS)
Non
existent
  1. Abbreviations: T2DM type 2 diabetes mellitus, R randomized, B blind, DB double-blind, SB single-blind, C crossover, P parallel, RS resistant starch, RDS rapidly digestible starch, w weeks